<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
    <channel>
        <title>我是弱者的凤凰博客</title>
        <link>http://blog.ifeng.com/2288721.html</link>
        <description><![CDATA[我是弱者的凤凰博客]]></description>
        <pubDate>Mon, 30 Nov 2009 13:40:44 +0800</pubDate>
        <lastBuildDate>Mon, 30 Nov 2009 13:40:44 +0800</lastBuildDate>
        <generator>REBORN 1.0(beta)</generator>
        <language>zh-cn</language>
                <item>
            <title><![CDATA[这样的再审案应该追加第三人出庭参加再审诉讼？]]></title>
            <link>http://blog.ifeng.com/article/2660369.html</link>
            <description><![CDATA[<P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -0.05pt; TEXT-INDENT: -3pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: -.25"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">注：此材料<SPAN lang=EN-US>8</SPAN>月<SPAN lang=EN-US>18</SPAN>日特快寄绍中院王育君院长，审监庭郭黎帆庭长（该案审判长）</SPAN><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt 9.15pt; TEXT-INDENT: 16.05pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .87gd; mso-char-indent-count: 1.0"><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">这样的再审案应该追加第三人出庭参加再审诉讼？</SPAN></B><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -0.05pt; TEXT-INDENT: -3pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: -.25"><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">_______________________</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">：</SPAN><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">我们是浙江省嵊州市医药药材总公司（以下简称医药公司）职工股东（作为利害关系人）向检察院申请抗诉</SPAN><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-bidi-font-family: 宋体">（</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">附件一、</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN lang=EN-US style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-bidi-font-family: 宋体">40</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-bidi-font-family: 宋体">位股东申请抗诉书）</SPAN></B><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">，经省检察院（<SPAN lang=EN-US>2007</SPAN>）浙检民行抗字第<SPAN lang=EN-US>85</SPAN>号民事抗诉书</SPAN><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">（附件二：省检民事抗诉书）</SPAN></B><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">向省高院提起抗诉，省高院（<SPAN lang=EN-US>2008</SPAN>）浙民监抗字第<SPAN lang=EN-US>38</SPAN>号裁定发回绍中院再审，绍中院按</SPAN><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-bidi-font-size: 14.0pt; mso-hansi-font-family: 宋体">原一审</SPAN></B><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">后</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体; mso-bidi-font-size: 14.0pt">再启动再审程序，</SPAN><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">应该</SPAN></B><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">追加确认我们有独立请求权的</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体; mso-font-kerning: 0pt">第三人出庭参加</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">再审</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体; mso-font-kerning: 0pt">诉讼依章依法公平公正再审？理由如下</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 宋体">：</SPAN><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -2.85pt; TEXT-INDENT: 24.1pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.27gd; mso-char-indent-count: 2.0"><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">一、</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-bidi-font-family: 宋体">排</SPAN></B><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-bidi-font-family: 宋体">除干扰，认定事实，</SPAN><SPAN style="FONT-SIZE: 12pt; LINE-HEIGHT: 120%; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">撤销增资变更登 ……<br/><br/>……</SPAN><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -2.85pt; TEXT-INDENT: 24.1pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.27gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt 0.1pt; TEXT-INDENT: -27.1pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -2.57gd; mso-char-indent-count: -2.25"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -0.05pt; TEXT-INDENT: -3pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: -.25"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt 0cm; TEXT-INDENT: -27pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -2.57gd; mso-char-indent-count: -2.25"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt 0cm; TEXT-INDENT: 132pt; LINE-HEIGHT: 120%; mso-para-margin-right: -.73gd; mso-char-indent-count: 11.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 132pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 11.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 132pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 11.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 132pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 11.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt 0cm; TEXT-INDENT: -27pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -2.57gd; mso-char-indent-count: -2.25"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.05pt; TEXT-INDENT: 264pt; LINE-HEIGHT: 120%; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -.29gd; mso-char-indent-count: 22.0"><P class=MsoNormal style="MARGIN: 0cm -7.65pt 0pt -3.35pt; TEXT-INDENT: -23.65pt; mso-para-margin-top: 0cm; mso-para-margin-right: -.73gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: -2.57gd; mso-char-indent-count: -2.25">]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2660369.html#comment</comments>
            <pubDate>Sat, 09 May 2009 16:14:39 +0800</pubDate>
            <guid>2660369</guid>
        </item>
                <item>
            <title><![CDATA[ 第四次请求 第三人出庭参加再审诉讼申请书]]></title>
            <link>http://blog.ifeng.com/article/2630987.html</link>
            <description><![CDATA[<STRONG><FONT size=4>                       第四次请求 第三人出庭参加再审诉讼申请书</FONT></STRONG><WBR><WBR><WBR><WBR>    申请人：沈洪钦等40位是浙江省嵊州市医药药材总公司股东，申请人是本案抗诉申诉人即利害关系人，从08年8月4日上午再审开庭的情况看，沒有追加第三人（即申请人）出庭参加再审有违法定程序，申请人（利害关系人）在前几次申请内容的前提下，更有必要再次向贵院申请。
<WBR><WBR><WBR>    请求事项：
<WBR><WBR><WBR> 追加申请人（利害关系人）以第三人身份出庭参加原审原告金樟林与原审被告浙江省嵊州市医药药材总公司股东权纠纷一案再审诉讼；再次开庭审理让第三人（利害关系人）出庭参加再审诉讼，<B>符合法定程序</B>。并提出独立请求：
<WBR><WBR><WBR>    1、驳回原审原 ……<br/><br/>……<WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR><WBR>]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2630987.html#comment</comments>
            <pubDate>Sat, 02 May 2009 14:51:15 +0800</pubDate>
            <guid>2630987</guid>
        </item>
                <item>
            <title><![CDATA[第三人出庭参加再审诉讼申请书（第三次申请）]]></title>
            <link>http://blog.ifeng.com/article/2628957.html</link>
            <description><![CDATA[<P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; LINE-HEIGHT: 35pt; TEXT-ALIGN: center; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-font-kerning: 0pt">第三人出庭参加</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体">再审</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-font-kerning: 0pt">诉讼申请书</SPAN></B><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">申请人：沈洪钦等<SPAN lang=EN-US>40</SPAN>位是浙江省嵊州市医药药材总公司股东，申请人是本案抗诉申诉人即利害关系人，现离<st1:chsdate w:st="on" Year="2008" Month="8" Day="4" IsLunarDate="False" IsROCDate="False"><SPAN lang=EN-US>08</SPAN>年<SPAN lang=EN-US>8</SPAN>月<SPAN lang=EN-US>4</SPAN>日</st1:chsdate>再审日期将近，申请人（利害关系人）再次向贵院申请。</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">请求事项：</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">追加申请人（利害关系人）以第三人身份出庭参加原告金樟林与被告浙江省嵊州市医药药材总公司股东权纠纷一案再审诉讼；并提出独立请求：</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">1</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">、驳回原告金樟林的诉讼请求；</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">2</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">、本案诉讼费用由原告承担。</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">事实与理由：；</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">一．</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-bidi-font-size: 14.0pt">本案现重新审理是由于申请人向检察机关申诉，而由检察机关</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">（<SPAN lang=EN-US>2007</SPAN>）浙检民行抗字第<SPAN lang=EN-US>85</SPAN>号民事抗诉书向省高院提起抗诉，省高院（<SPAN lang=EN-US>2008</SPAN>）浙民监抗字第<SPAN lang=EN-US>38</SPAN>号裁定发回贵院再审，贵院</SPAN><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-bidi-font-size: 14.0pt">原一审</SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">后</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-bidi-font-size: 14.0pt">再启动再审程序的，</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">开 ……<br/><br/>……</SPAN><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 175.8pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 14.65"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 120pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 10.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 120pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 10.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 180pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 15.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 180pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 15.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 180pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 15.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 180pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 15.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; TEXT-INDENT: 228pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-char-indent-count: 19.0"><P class=MsoNormal style="MARGIN: 0cm 10.5pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: 1.0gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd">]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2628957.html#comment</comments>
            <pubDate>Fri, 01 May 2009 21:31:30 +0800</pubDate>
            <guid>2628957</guid>
        </item>
                <item>
            <title><![CDATA[省检是这么抗诉的]]></title>
            <link>http://blog.ifeng.com/article/2624446.html</link>
            <description><![CDATA[<P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 24pt; FONT-FAMILY: 黑体; mso-bidi-font-size: 12.0pt">浙 江 省 人 民 检 察 院</SPAN></B><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-ALIGN: center" align=center><B><SPAN style="FONT-SIZE: 26pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-ascii-font-family: 'Times New Roman'">民事抗诉书</SPAN></B><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 30pt; TEXT-ALIGN: right; mso-line-height-rule: exactly" align=right><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-ascii-font-family: 'Times New Roman'">（</SPAN><SPAN lang=EN-US style="FONT-SIZE: 14pt; mso-bidi-font-size: 12.0pt">2007</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-ascii-font-family: 'Times New Roman'">）浙检民行抗字第</SPAN><SPAN lang=EN-US style="FONT-SIZE: 14pt; mso-bidi-font-size: 12.0pt">85</SPAN><SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-bidi-font-size: 12.0pt; mso-ascii-font-family: 'Times New Roman'">号</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 30pt; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">沈洪钦等</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">40</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">位嵊州市医药药材总公司股东系金樟林、浙江省嵊州市医药药材总公司股东权纠纷一案的利害关系人，其不服绍兴市中级人民法院（</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">2006</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">）绍中民二初字第</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">123</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">号民事判决，向检察机关申诉。绍兴市人民检察院提请本院抗诉，本院依法对该案进行了审查。</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">申诉人（案外人）浙江省嵊州市医药药材总公司</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">40</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">位股东。诉讼代表人沈洪钦，男，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">54</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">岁，汉族，住嵊州市雅石路</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">1</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">号。诉讼代表人陈洪明，男，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">39</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">岁，汉族，住嵊州市南马路</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">171</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">号</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">6</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">单元</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">601</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">室。</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">被申诉人（原审原告）金樟林，男，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">1958</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">年</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">3</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">月</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">17</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">日出生，汉族，住嵊州市剡湖街道龙会中路</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">30</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">号</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt">401</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: 'Times New Roman'; mso-ascii-font-family: 'Times New Roman'">室 ……<br/><br/>……</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoSalutation style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 18pt; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 18pt; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 18pt; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 276pt; LINE-HEIGHT: 30pt; mso-line-height-rule: exactly; mso-char-indent-count: 23.0"><P class=MsoDate style="MARGIN: 0cm 0cm 0pt 262.5pt; TEXT-INDENT: 12pt; LINE-HEIGHT: 30pt; mso-line-height-rule: exactly; mso-char-indent-count: 1.0"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 21pt; mso-line-height-rule: exactly">]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2624446.html#comment</comments>
            <pubDate>Thu, 30 Apr 2009 12:49:55 +0800</pubDate>
            <guid>2624446</guid>
        </item>
                <item>
            <title><![CDATA[追加确认申诉人为第三人出庭参加再审诉讼申请书]]></title>
            <link>http://blog.ifeng.com/article/2624416.html</link>
            <description><![CDATA[<P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; LINE-HEIGHT: 35pt; TEXT-ALIGN: center; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">追加确认申诉人为</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-font-kerning: 0pt">第三人出庭参加</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体">再审</SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 16pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-font-kerning: 0pt">诉讼申请书</SPAN></B><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">申请人：沈洪钦等<SPAN lang=EN-US>40</SPAN>位是浙江省嵊州市医药药材总公司股东，申请人是本案抗诉申诉人即利害关系人，我们申诉人已于<SPAN lang=EN-US>08</SPAN>年<SPAN lang=EN-US>7</SPAN>月<SPAN lang=EN-US>6</SPAN>日特快寄给贵院审监庭，向绍兴市中级人民法院打了《</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体; mso-ascii-font-family: 宋体">关于申诉人请求出庭参加再审的报告</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">》，未见支持，还有与本案相关的事实依据也向贵院审监庭反映了，现离<SPAN lang=EN-US>08</SPAN>年<SPAN lang=EN-US>8</SPAN>月<SPAN lang=EN-US>4</SPAN>日再审日期将近，申请人（申诉人即利害关系人）再次向贵院申请。</SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">请求事项：</SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">1</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">．请求贵院追加确认申请人（申诉人即利害关系人）为第三人身份出庭参加金樟林与浙江省嵊州市医药药材总公司股东权纠纷一案再审诉讼；</SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">2</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">．并提出独立请求：驳回原告金樟林的诉讼请求。</SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体">事实与理由：；</SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 黑体; mso-hansi-font-family: 宋体">一．</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-bidi-font-size: 14.0pt">本案现重新审理是由于申 ……<br/><br/>……</SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 2.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 144pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 12.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 144pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 12.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 144pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 12.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 144pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 12.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 144pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 12.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; TEXT-INDENT: 240pt; LINE-HEIGHT: 25pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; mso-line-height-rule: exactly; mso-char-indent-count: 20.0"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd"><SPAN lang=EN-US><P class=MsoNormal style="MARGIN: 0cm 27pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: 2.57gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; tab-stops: 585.0pt"></SPAN><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd"><P class=MsoNormal style="MARGIN: 0cm 1.55pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: .15gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd"><SPAN lang=EN-US><P class=MsoNormal style="MARGIN: 0cm 27pt 0pt 8.9pt; mso-para-margin-top: 0cm; mso-para-margin-right: 2.57gd; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .85gd; tab-stops: 585.0pt"></SPAN>]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2624416.html#comment</comments>
            <pubDate>Thu, 30 Apr 2009 12:35:57 +0800</pubDate>
            <guid>2624416</guid>
        </item>
                <item>
            <title><![CDATA[草稿(2009-04-28 19:09:51)]]></title>
            <link>http://blog.ifeng.com/article/2616885.html</link>
            <description><![CDATA[转载
         浙江省绍中院（2006）绍中民二初字第123号民事判决书主要是大家看看绍中院对股东代表大会决议是怎么判的，有一个了解的过程。]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2616885.html#comment</comments>
            <pubDate>Tue, 28 Apr 2009 19:09:18 +0800</pubDate>
            <guid>2616885</guid>
        </item>
                <item>
            <title><![CDATA[民 事 抗 诉 申 请 书]]></title>
            <link>http://blog.ifeng.com/article/2607835.html</link>
            <description><![CDATA[<P class=MsoNormal style="MARGIN: 7.8pt 0cm; TEXT-INDENT: 126.5pt; LINE-HEIGHT: 150%; TEXT-ALIGN: left; mso-pagination: widow-orphan; mso-para-margin-top: .5gd; mso-para-margin-right: 0cm; mso-para-margin-bottom: .5gd; mso-para-margin-left: 0cm; mso-char-indent-count: 7.0" align=left><B><SPAN style="FONT-SIZE: 18pt; LINE-HEIGHT: 150%; FONT-FAMILY: 黑体; mso-bidi-font-size: 12.0pt; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体; mso-hansi-font-family: 宋体">民 事 抗 诉 申 请 书</SPAN></B><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 23.95pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-para-margin-left: 2.28gd; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">申诉人：浙江省嵊州市医药药材总公司<SPAN lang=EN-US>40</SPAN>位股东</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt"></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">诉讼代表人：沈洪钦，男，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">54</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">岁，汉族，住嵊州市雅石路</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">1</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">号</SPAN><SPAN style="FONT-SIZE: 9pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体"><SPAN lang=EN-US></SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">诉讼代表人：陈洪明，男，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">39</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">岁，汉族，住嵊州市南马路</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">171</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">号</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">6</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">单元</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">601</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">室</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 23.95pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-para-margin-left: 2.28gd; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">被申诉人： 金樟林，</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">男，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">1958</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">年</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">3</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">月</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">17</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">日，汉族，住嵊州市剡湖街道龙会中</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 23.95pt; TEXT-INDENT: 66pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-para-margin-left: 2.28gd; mso-char-indent-count: 5.5; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">路</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">30</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">号</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">401</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">室</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">被申诉人：浙江省嵊州市医药药材总公司，法定代表人：裘星职务：董事长</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 78pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-char-indent-count: 6.5; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">住址：嵊州市越秀北路<SPAN lang=EN-US>66</SPAN>号</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">申诉人因是两被申诉人股东权纠纷一案的利害关系人，该案已经由绍兴市中级人民法院（以下简称绍中院）作出</SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt">(2006)</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">绍中民二初字第<SPAN lang=EN-US>123</SPAN>号民事判决并已生效</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: Arial; mso-hansi-font-family: Arial; mso-ascii-font-family: Arial">，</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-hansi-font-family: ˎ̥; mso-ascii-font-family: ˎ̥">申请人认为该判决认定事实及适用法律错误，</SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体">特请求贵院依审判监督程序进 ……<br/><br/>……</SPAN><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 6pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-para-margin-left: .57gd; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 6pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-para-margin-left: .57gd; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 0cm 0cm 0pt 6pt; TEXT-INDENT: 24pt; LINE-HEIGHT: 23pt; mso-pagination: widow-orphan; mso-para-margin-left: .57gd; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-font-kerning: 0pt"></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体"><SPAN lang=EN-US></SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体"><SPAN lang=EN-US></SPAN></SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体"></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体"><SPAN lang=EN-US></SPAN></SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt; FONT-FAMILY: 宋体; mso-font-kerning: 0pt; mso-bidi-font-family: 宋体"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 12pt"></SPAN><P class=MsoSalutation style="MARGIN: 2.5pt 0cm; TEXT-INDENT: 54pt; LINE-HEIGHT: 22pt; mso-char-indent-count: 4.5; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 2.5pt 0cm; TEXT-INDENT: 24pt; LINE-HEIGHT: 22pt; mso-char-indent-count: 2.0; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 2.5pt 0cm; TEXT-INDENT: 108pt; LINE-HEIGHT: 22pt; mso-char-indent-count: 9.0; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 2.5pt 0cm; TEXT-INDENT: 108pt; LINE-HEIGHT: 22pt; mso-char-indent-count: 9.0; mso-line-height-rule: exactly"><P class=MsoNormal style="MARGIN: 2.5pt 0cm; TEXT-INDENT: 294pt; LINE-HEIGHT: 22pt; mso-char-indent-count: 24.5; mso-line-height-rule: exactly"><SPAN style="FONT-SIZE: 12pt; COLOR: black; FONT-FAMILY: 宋体; mso-hansi-font-family: ˎ̥; mso-ascii-font-family: ˎ̥"><P class=MsoNormal style="MARGIN: 2.5pt -25.7pt 2.5pt 30.05pt; TEXT-INDENT: -48pt; LINE-HEIGHT: 22pt; mso-para-margin-top: 2.5pt; mso-para-margin-right: -2.45gd; mso-para-margin-bottom: 2.5pt; mso-para-margin-left: -1.71gd; mso-char-indent-count: -4.0; mso-line-height-rule: exactly"></SPAN><P class=MsoNormal style="MARGIN: 2.5pt 0cm; TEXT-INDENT: 294pt; LINE-HEIGHT: 22pt; mso-char-indent-count: 24.5; mso-line-height-rule: exactly">]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2607835.html#comment</comments>
            <pubDate>Sun, 26 Apr 2009 19:01:50 +0800</pubDate>
            <guid>2607835</guid>
        </item>
                <item>
            <title><![CDATA[这样的股东代表大会决议合法吗]]></title>
            <link>http://blog.ifeng.com/article/2607498.html</link>
            <description><![CDATA[       浙江省嵊州市医药药材总公司原董事长金樟林（05年10月11日因虚开发票骗取国家税款被判缓刑的带刑之人未期满）作为原告于2006年3月6日诉被告医药总公司股东权纠纷一案，向绍中院提起诉讼，诉请：1、确认2000年9月27日被告股东代表大会通过《医药公司增资扩股方案》的决议合法有效。2、确认原告于2000年 10月17日向被告缴纳881600元新增股本金的行为合法有效；确认原告上述新增881600元股本金目前已增值138400元，合计102万元。3、本案诉讼费由被告承担。于2006年4月19日开庭审理，同月20日进行了判决：确认2000年9月27日被告医药总公司股东代表大会通过《医药 ……<br/><br/>……]]></description>
            <author>我是弱者</author>
            <comments>http://blog.ifeng.com/article/2607498.html#comment</comments>
            <pubDate>Sun, 26 Apr 2009 17:15:47 +0800</pubDate>
            <guid>2607498</guid>
        </item>
            </channel>
</rss>